KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Equity (2016 - 2025)

Historic Return on Equity for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to 0.04%.

  • Fulgent Genetics' Return on Equity rose 1000.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.04% for FY2024, which is 1000.0% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Return on Equity is 0.04%, which was up 1000.0% from 0.05% recorded in Q2 2025.
  • Fulgent Genetics' Return on Equity's 5-year high stood at 0.61% during Q1 2021, with a 5-year trough of 0.14% in Q1 2024.
  • For the 5-year period, Fulgent Genetics' Return on Equity averaged around 0.12%, with its median value being 0.04% (2025).
  • In the last 5 years, Fulgent Genetics' Return on Equity soared by 6100bps in 2021 and then tumbled by -3900bps in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Return on Equity stood at 0.45% in 2021, then tumbled by -76bps to 0.11% in 2022, then tumbled by -223bps to 0.14% in 2023, then skyrocketed by 72bps to 0.04% in 2024, then decreased by -2bps to 0.04% in 2025.
  • Its Return on Equity was 0.04% in Q3 2025, compared to 0.05% in Q2 2025 and 0.04% in Q1 2025.